GUERBET (GBT.PA) Fundamental Analysis & Valuation
EPA:GBT • FR0000032526
Current stock price
11.54 EUR
+1.44 (+14.26%)
Last:
This GBT.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. GBT.PA Profitability Analysis
1.1 Basic Checks
- GBT had negative earnings in the past year.
- GBT had a positive operating cash flow in the past year.
- In multiple years GBT reported negative net income over the last 5 years.
- In the past 5 years GBT always reported a positive cash flow from operatings.
1.2 Ratios
- Looking at the Return On Assets, with a value of -11.65%, GBT is doing worse than 70.49% of the companies in the same industry.
- The Return On Equity of GBT (-40.57%) is worse than 75.41% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -11.65% | ||
| ROE | -40.57% | ||
| ROIC | N/A |
ROA(3y)-2.59%
ROA(5y)-1.78%
ROE(3y)-10.06%
ROE(5y)-6.59%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- GBT's Operating Margin has declined in the last couple of years.
- GBT has a better Gross Margin (75.59%) than 88.52% of its industry peers.
- GBT's Gross Margin has been stable in the last couple of years.
- GBT does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 75.59% |
OM growth 3Y-43.49%
OM growth 5Y-29.74%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.86%
GM growth 5Y-0.42%
2. GBT.PA Health Analysis
2.1 Basic Checks
- GBT does not have a ROIC to compare to the WACC, probably because it is not profitable.
- Compared to 1 year ago, GBT has about the same amount of shares outstanding.
- The number of shares outstanding for GBT remains at a similar level compared to 5 years ago.
- GBT has a worse debt/assets ratio than last year.
2.2 Solvency
- GBT has an Altman-Z score of 1.59. This is a bad value and indicates that GBT is not financially healthy and even has some risk of bankruptcy.
- Looking at the Altman-Z score, with a value of 1.59, GBT is doing worse than 68.85% of the companies in the same industry.
- The Debt to FCF ratio of GBT is 9.84, which is on the high side as it means it would take GBT, 9.84 years of fcf income to pay off all of its debts.
- GBT has a Debt to FCF ratio (9.84) which is comparable to the rest of the industry.
- GBT has a Debt/Equity ratio of 1.47. This is a high value indicating a heavy dependency on external financing.
- Looking at the Debt to Equity ratio, with a value of 1.47, GBT is doing worse than 78.69% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.47 | ||
| Debt/FCF | 9.84 | ||
| Altman-Z | 1.59 |
ROIC/WACCN/A
WACC6.25%
2.3 Liquidity
- GBT has a Current Ratio of 2.49. This indicates that GBT is financially healthy and has no problem in meeting its short term obligations.
- Looking at the Current ratio, with a value of 2.49, GBT is in the better half of the industry, outperforming 68.85% of the companies in the same industry.
- GBT has a Quick Ratio of 1.27. This is a normal value and indicates that GBT is financially healthy and should not expect problems in meeting its short term obligations.
- GBT's Quick ratio of 1.27 is in line compared to the rest of the industry. GBT outperforms 59.02% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.49 | ||
| Quick Ratio | 1.27 |
3. GBT.PA Growth Analysis
3.1 Past
- The earnings per share for GBT have decreased strongly by -769.32% in the last year.
- Looking at the last year, GBT shows a decrease in Revenue. The Revenue has decreased by -6.50% in the last year.
- Measured over the past years, GBT shows a small growth in Revenue. The Revenue has been growing by 2.00% on average per year.
EPS 1Y (TTM)-769.32%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2277.6%
Revenue 1Y (TTM)-6.5%
Revenue growth 3Y1.45%
Revenue growth 5Y2%
Sales Q2Q%-5.5%
3.2 Future
- GBT is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 100.64% yearly.
- The Revenue is expected to grow by 1.03% on average over the next years.
EPS Next Y-417.31%
EPS Next 2Y275.2%
EPS Next 3Y100.64%
EPS Next 5YN/A
Revenue Next Year-5.17%
Revenue Next 2Y0.06%
Revenue Next 3Y1.03%
Revenue Next 5YN/A
3.3 Evolution
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. GBT.PA Valuation Analysis
4.1 Price/Earnings Ratio
- GBT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
- Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for GBT. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
- Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of GBT indicates a rather cheap valuation: GBT is cheaper than 95.08% of the companies listed in the same industry.
- 100.00% of the companies in the same industry are more expensive than GBT, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 3.28 | ||
| EV/EBITDA | 4.84 |
4.3 Compensation for Growth
- GBT's earnings are expected to grow with 100.64% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y275.2%
EPS Next 3Y100.64%
5. GBT.PA Dividend Analysis
5.1 Amount
- With a Yearly Dividend Yield of 2.69%, GBT has a reasonable but not impressive dividend return.
- Compared to an average industry Dividend Yield of 1.26, GBT pays a better dividend. On top of this GBT pays more dividend than 81.97% of the companies listed in the same industry.
- GBT's Dividend Yield is a higher than the S&P500 average which is at 1.81.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.69% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DP0%
EPS Next 2Y275.2%
EPS Next 3Y100.64%
GBT.PA Fundamentals: All Metrics, Ratios and Statistics
EPA:GBT (4/24/2026, 4:37:43 PM)
11.54
+1.44 (+14.26%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)03-11 2026-03-11
Earnings (Next)04-23 2026-04-23
Inst Owners8.83%
Inst Owner ChangeN/A
Ins Owners5.01%
Ins Owner ChangeN/A
Market Cap145.87M
Revenue(TTM)786.44M
Net Income(TTM)-108.33M
Analysts44
Price Target12.19 (5.63%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.69% |
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-11.81%
PT rev (3m)-8.08%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-78.86%
EPS NY rev (3m)-138.02%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-1.15%
Revenue NY rev (3m)-8.99%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.19 | ||
| P/FCF | 3.28 | ||
| P/OCF | 1.8 | ||
| P/B | 0.55 | ||
| P/tB | 0.71 | ||
| EV/EBITDA | 4.84 |
EPS(TTM)-8.5
EYN/A
EPS(NY)-0.56
Fwd EYN/A
FCF(TTM)3.52
FCFY30.49%
OCF(TTM)6.42
OCFY55.59%
SpS62.22
BVpS21.12
TBVpS16.26
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -11.65% | ||
| ROE | -40.57% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 75.59% | ||
| FCFM | 5.66% |
ROA(3y)-2.59%
ROA(5y)-1.78%
ROE(3y)-10.06%
ROE(5y)-6.59%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)4.11%
ROCE(5y)4.72%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-43.49%
OM growth 5Y-29.74%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.86%
GM growth 5Y-0.42%
F-Score4
Asset Turnover0.85
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.47 | ||
| Debt/FCF | 9.84 | ||
| Debt/EBITDA | 5.29 | ||
| Cap/Depr | 22.55% | ||
| Cap/Sales | 4.66% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | 109.34% | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.49 | ||
| Quick Ratio | 1.27 | ||
| Altman-Z | 1.59 |
F-Score4
WACC6.25%
ROIC/WACCN/A
Cap/Depr(3y)65.96%
Cap/Depr(5y)64.56%
Cap/Sales(3y)6.22%
Cap/Sales(5y)6.41%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-769.32%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2277.6%
EPS Next Y-417.31%
EPS Next 2Y275.2%
EPS Next 3Y100.64%
EPS Next 5YN/A
Revenue 1Y (TTM)-6.5%
Revenue growth 3Y1.45%
Revenue growth 5Y2%
Sales Q2Q%-5.5%
Revenue Next Year-5.17%
Revenue Next 2Y0.06%
Revenue Next 3Y1.03%
Revenue Next 5YN/A
EBIT growth 1Y-277.86%
EBIT growth 3Y-42.67%
EBIT growth 5Y-28.34%
EBIT Next Year317.55%
EBIT Next 3Y81.45%
EBIT Next 5YN/A
FCF growth 1Y83.59%
FCF growth 3YN/A
FCF growth 5Y-6.04%
OCF growth 1Y-0.16%
OCF growth 3Y38.62%
OCF growth 5Y-7.61%
GUERBET / GBT.PA Fundamental Analysis FAQ
What is the fundamental rating for GBT stock?
ChartMill assigns a fundamental rating of 3 / 10 to GBT.PA.
What is the valuation status of GUERBET (GBT.PA) stock?
ChartMill assigns a valuation rating of 3 / 10 to GUERBET (GBT.PA). This can be considered as Overvalued.
Can you provide the profitability details for GUERBET?
GUERBET (GBT.PA) has a profitability rating of 2 / 10.
Can you provide the financial health for GBT stock?
The financial health rating of GUERBET (GBT.PA) is 3 / 10.
Can you provide the expected EPS growth for GBT stock?
The Earnings per Share (EPS) of GUERBET (GBT.PA) is expected to decline by -417.31% in the next year.